Avanos Medical earnings were -$463.2M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest AVNS earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$76.8M, down 1,263.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AVNS reported annual earnings of -$392.1M, with 534.5% growth.
On AVNS's earnings call on Invalid Date, Avanos Medical (NYSE: AVNS) reported Q2 2025 earnings per share (EPS) of -$1.66, up 4,250% year over year. Total AVNS earnings for the quarter were -$76.80 million. In the same quarter last year, Avanos Medical's earnings per share (EPS) was $0.04.
As of the last Avanos Medical earnings report, Avanos Medical is currently losing money. Avanos Medical's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$463.20 million, a 6,115.58% decrease year over year.
What was AVNS's earnings growth in the past year?
As of Avanos Medical's earnings date in Invalid Date, Avanos Medical's earnings has grown year over year. AVNS earnings in the past year totalled -$463.20 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.